Keiko Tamura

Keiko Tamura

Auto-generated profile, based on publicly available information

Keiko Tamura

Center for Industrial Research and Innovation, Osaka Dental University (K.T.), Osaka, Japan

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2023 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
KIKaori Ichihara
Kaori Ichihara
CNChika Nishiyama
Chika Nishiyama
KKKosuke Kiyohara
Kosuke Kiyohara
TMTatsuya Morita
Tatsuya Morita
KTKeiko Tamura
Keiko Tamura

3 September 2024 in Journal of Pain and Symptom Management
Verified
Journal Article
Open access
STSayaka Takenouchi
Sayaka Takenouchi
YUYu Uneno
Yu Uneno
SMShigemi Matsumoto
Shigemi Matsumoto
ACAi Chikada
Ai Chikada
RURyuji Uozumi
Ryuji Uozumi
MMMasanori Mori
Masanori Mori
Cultural adaptation is essential for optimizing programs centered around autonomy, such as the Serious Illness Care Program (SICP), especially for populations valuing family-involved decision-making. We aimed to evaluate the feasibility and efficacy of a culturally adapted SICP-based nurse-physician collaborative Advance Care Planning (ACP) intervention tailored for patients with advanced cancer who prefer family-involved decision-making. Oncology nurses, extensively trained and closely collaborating with physicians, conducted structured discussions with patients in the intervention group. The culturally adapted SICP-based ACP intervention was supplemented with trust-building, family involvement, and understanding of patient values. Primary inclusion criteria included patients within six weeks of initiating first-line palliative chemotherapy. Primary endpoints were achieving a 70% completion rate and assessing spiritual well-being (FACIT-Sp) at six months. Secondary endpoints included anxiety (GAD-7), depression (PHQ-9), quality of life (QOL) (CoQoLo), and ACP progress (ACP Engagement Scale) at the same interval. Forty-one patients (67.2%) completed the six-month follow-up, falling short of the targeted completion rate. The least-squares mean change from baseline in spiritual well-being at six months was 3.00 in the intervention group and -2.22 in the standard care group (difference, 5.22 points; 95% confidence interval, 1.38-9.06; p = .009). Similar superiority of the intervention was observed in QOL and ACP progress. Despite not meeting the targeted completion rate, the intervention group demonstrated enhanced spiritual well-being, QOL, and ACP progress. Our findings suggest revisions to the intervention manual to improve feasibility and to progress to an efficacy-focused randomized controlled trial.